Velocity Financial, Inc.
Velocity Financial, Inc. (VEL) Stock News
The latest VEL headlines and market coverage — 7 recent stories, updated throughout the day.
- GlobeNewswire Inc.·Neutral
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026
Tenax Therapeutics presented additional Phase 3 LEVEL trial results for TNX-103 (oral levosimendan) in patients with pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). While the primary endpoint of 6-minute walk distance improvement did not achieve statistical significance in the overall population, prespecified subgroup analyses showed favorable results in patients with baseline 6MWD below 333 meters, including a 26.3-meter improvement in walk distance and a 47% reduction in NT-proBNP. The company plans to enrich the LEVEL-2 trial population based on these findings.
- GlobeNewswire Inc.·
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
CLINUVEL Pharmaceuticals announced its tenth consecutive annual profit for FY2026 with revenues of $94.0 million and net profit after tax of $33.9 million. The company declared a $0.05 per share dividend and increased cash reserves to $252.1 million, providing financial independence to pursue expansion strategy, particularly in North America. Despite marginal revenue decline due to U.S. market competition and inventory practice changes, the company maintained disciplined expense control and achieved record SCENESSE treatment volumes.
- GlobeNewswire Inc.·Neutral
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
CLINUVEL Pharmaceuticals announced a strategic reorganisation effective January 1, 2027, relocating its corporate headquarters from Australia to the United States and reducing its global workforce by 10-20%. The restructuring aims to strengthen U.S. regulatory engagement, focus operations on the U.S. pharmaceutical market, and unlock deeper capital pools from U.S. investors who prefer U.S.-listed companies. The move is driven by the company's recognition that U.S.-listed specialty pharma companies command higher valuation multiples and that over 66% of its shareholder base is already foreign investors.
- GlobeNewswire Inc.·
AMERANT INVESTMENTS APPOINTS RICARDO SUCRE TO LEAD INTERNATIONAL WEALTH MANAGEMENT BUSINESS DEVELOPMENT
Amerant Investments announced the appointment of Ricardo Sucre as Head of International Wealth Management Business Development. Sucre brings over 20 years of experience from leading financial institutions including Morgan Stanley and Bolton Global Capital. The appointment reflects Amerant's strategic focus on expanding its international wealth management platform and attracting experienced financial advisors to its integrated banking and investment services model.
- GlobeNewswire Inc.·
LANCASTER AVENUE 21ST COMMUNITY DEVELOPMENT CORPORATION RECEIVES TRUIST FOUNDATION SUPPORT TO STRENGTHEN SMALL BUSINESS INITIATIVE AND PHILADELPHIA ENTREPRENEURS
LA21-CDC received grant support from Truist Foundation to expand its Small Business Sustainability Initiative, which provides Philadelphia entrepreneurs with coaching, business systems training, capital readiness support, and AI-powered business tools to strengthen operations and build long-term sustainability.
- GlobeNewswire Inc.·Neutral
HAMANASI ADVENTURE & DIVE RESORT, BELIZE RANKED #1 HOTEL IN CENTRAL AMERICA AND #15 IN THE WORLD IN 2026 TRIPADVISOR TRAVELERS’ CHOICE BEST OF THE BEST AWARDS
Hamanasi Adventure & Dive Resort in Belize has been recognized as the #1 hotel in Central America and #15 best hotel globally in the 2026 TripAdvisor Travelers' Choice Best of the Best Awards. The luxury boutique resort, which employs over 180 Belizean staff, was recognized for exceptional service and guest experiences. The award is given to fewer than 1% of TripAdvisor's 8 million listings.
- Benzinga·
NATURE'S MIRACLE HOLDING INC. ANNOUNCES STRATEGIC MOU WITH DROMNI INTELLIGENCE TO DEVELOP AI-POWERED AUTONOMOUS ROBOTICS SOLUTIONS FOR U.S. AGRICULTURE, ENERGY AND DATA CENTER MARKETS
Nature's Miracle Holding Inc. has entered into a Memorandum of Understanding with DROMNI Intelligence Technology Ltd. to collaborate on developing and commercializing AI-enabled autonomous robotics solutions for the U.S. agriculture, energy, and data center markets. The partnership will focus on unmanned ground vehicle deployment, smart infrastructure automation, and pilot programs across greenhouse operations, logistics, energy infrastructure, and industrial automation.